@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
  @prefix cc: <http://creativecommons.org/ns#> .
  @prefix bibo: <http://purl.org/ontology/bibo/> .
  @prefix owl: <http://www.w3.org/2002/07/owl#> .
  @prefix foaf: <http://xmlns.com/foaf/0.1/> .
  @prefix skos: <http://www.w3.org/2004/02/skos/core#> .
  @prefix void: <http://rdfs.org/ns/void#> .
  @prefix ep: <http://eprints.org/ontology/> .
  @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
  @prefix dct: <http://purl.org/dc/terms/> .
  @prefix eprel: <http://eprints.org/relation/> .
  @prefix geo: <http://www.w3.org/2003/01/geo/wgs84_pos#> .
  @prefix event: <http://purl.org/NET/c4dm/event.owl#> .
  @prefix doi: <https://doi.org/> .
  @prefix epid: <https://arxiv.universalpublishings.com/id/> .
  @prefix dc: <http://purl.org/dc/elements/1.1/> .
  @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

<>
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/83006>;
	rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/83006#authors>
	rdf:_1 <https://arxiv.universalpublishings.com/id/person/ext-fec8d510264e3e6effa2eb1b8d97d574> .

<https://arxiv.universalpublishings.com/id/eprint/83006/>
	dc:format "text/html";
	dc:title "HTML Summary of #83006 \n\nADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE\n\n";
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/83006> .

<https://arxiv.universalpublishings.com/id/eprint/83006>
	bibo:abstract "Multiple sclerosis (MS) is a chronic, immune-mediated neurological disorder characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Over the past two decades, the management of MS has evolved dramatically, transitioning from limited immunomodulatory options to a broad spectrum of disease-modifying therapies and emerging personalized medicine approaches. Advances in immunotherapy have significantly reduced relapse rates and delayed disease progression, while novel biomarkers, genetic profiling, and neuroimaging techniques have enabled more individualized treatment strategies. This article reviews recent advances in the management of multiple sclerosis, focusing on immunotherapeutic developments, emerging treatment modalities, and the growing role of personalized medicine in optimizing patient outcomes.\n&nbsp;"^^xsd:string;
	bibo:authorList <https://arxiv.universalpublishings.com/id/eprint/83006#authors>;
	bibo:status <http://purl.org/ontology/bibo/status/published>;
	dct:creator <https://arxiv.universalpublishings.com/id/person/ext-fec8d510264e3e6effa2eb1b8d97d574>;
	dct:date "2026-02-27";
	dct:isPartOf <https://arxiv.universalpublishings.com/id/repository>,
		<https://arxiv.universalpublishings.com/id/publication/ext-49f627dc2163f33bc2f328f6bf0ceed7>;
	dct:publisher <https://arxiv.universalpublishings.com/id/org/ext-d242a9f5e40e767de537eb4bf3f2e146>;
	dct:title "ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE"^^xsd:string;
	rdf:type bibo:AcademicArticle,
		bibo:Article,
		ep:ArticleEPrint,
		ep:EPrint;
	rdfs:seeAlso <https://arxiv.universalpublishings.com/id/eprint/83006/> .

<https://arxiv.universalpublishings.com/id/org/ext-d242a9f5e40e767de537eb4bf3f2e146>
	foaf:name "Research Science and Innovation house"^^xsd:string;
	rdf:type foaf:Organization .

<https://arxiv.universalpublishings.com/id/person/ext-fec8d510264e3e6effa2eb1b8d97d574>
	foaf:familyName "qizi"^^xsd:string;
	foaf:givenName "Abduraupova Maftuna Yunusjon"^^xsd:string;
	foaf:name "Abduraupova Maftuna Yunusjon qizi"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/publication/ext-49f627dc2163f33bc2f328f6bf0ceed7>
	foaf:name "MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE"^^xsd:string;
	rdf:type bibo:Collection .